{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:48:19Z","timestamp":1792612099067,"version":"4.5.0"},"reference-count":40,"publisher":"MyJove Corporation","issue":"186","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/64265","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T20:00:10Z","timestamp":1659643210000},"source":"Crossref","is-referenced-by-count":7,"title":["Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes"],"prefix":"10.3791","author":[{"given":"Shane Rui","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Mond\u00e9jar-Parre\u00f1o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengcheng","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph C.","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2022,8,4]]},"reference":[{"issue":"9","key":"ref1","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.2020.1166","type":"journal-article","article-title":"Estimated research and development investment needed to bring a new medicine to market, 2009-2018","volume":"323","author":"Wouters","year":"2020","unstructured":"Wouters, O. J., McKee, M., Luyten, J. Estimated research and development investment needed to bring a new medicine to market, 2009-2018. Journal of the American Medical Association. 323 (9), 844-853 (2020).","journal-title":"Journal of the American Medical Association"},{"issue":"9","key":"ref2","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/CIRCRESAHA.119.315378","type":"journal-article","article-title":"Workshop report: FDA workshop on improving cardiotoxicity assessment with human-relevant platforms","volume":"125","author":"Pang","year":"2019","unstructured":"Pang, L. et al. Workshop report: FDA workshop on improving cardiotoxicity assessment with human-relevant platforms. Circulation Research. 125 (9), 855-867 (2019).","journal-title":"Circulation Research"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"100216","DOI":"10.1016\/j.xcrm.2021.100216","type":"journal-article","article-title":"Toward a broader view of mechanisms of drug cardiotoxicity","volume":"2","author":"Mamoshina","year":"2021","unstructured":"Mamoshina, P., Rodriguez, B., Bueno-Orovio, A. Toward a broader view of mechanisms of drug cardiotoxicity. Cell Reports Medicine. 2 (3), 100216 (2021).","journal-title":"Cell Reports Medicine"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1124\/pr.116.013003","type":"journal-article","article-title":"Patient and disease-specific induced pluripotent stem cells for discovery of personalized cardiovascular drugs and therapeutics","volume":"72","author":"Paik","year":"2020","unstructured":"Paik, D. T., Chandy, M., & Wu, J. C. Patient and disease-specific induced pluripotent stem cells for discovery of personalized cardiovascular drugs and therapeutics. Pharmacological Reviews. 72 (1), 320-342 (2020).","journal-title":"Pharmacological Reviews"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3389\/fphys.2012.00345","type":"journal-article","article-title":"Cardiac electrophysiology in mice: a matter of size","volume":"3","author":"Kaese","year":"2012","unstructured":"Kaese, S., Verheule, S. Cardiac electrophysiology in mice: a matter of size. Frontiers in Physiology. 3, 345 (2012).","journal-title":"Frontiers in Physiology"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1016\/S0021-9258(19)83798-5","type":"journal-article","article-title":"Species correlations between cardiac isomyosins. A comparison of electrophoretic and immunological properties","volume":"257","author":"Clark","year":"1982","unstructured":"Clark, W. A., Jr., Chizzonite, R. A., Everett, A. W., Rabinowitz, M., Zak, R. Species correlations between cardiac isomyosins. A comparison of electrophoretic and immunological properties. Journal of Biological Chemistry. 257 (10), 5449-5454 (1982).","journal-title":"Journal of Biological Chemistry"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.yjmcc.2016.07.007","type":"journal-article","article-title":"Characterization of circular RNAs in human, mouse, and rat hearts","volume":"98","author":"Werfel","year":"2016","unstructured":"Werfel, S. et al. Characterization of circular RNAs in human, mouse, and rat hearts. Journal of Molecular and Cellular Cardiology. 98, 103-107 (2016).","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"8","key":"ref8","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/nmeth.2999","type":"journal-article","article-title":"Chemically defined generation of human cardiomyocytes","volume":"11","author":"Burridge","year":"2014","unstructured":"Burridge, P. W. et al. Chemically defined generation of human cardiomyocytes. Nature Methods. 11 (8), 855-860 (2014).","journal-title":"Nature Methods"},{"issue":"97","key":"ref9","first-page":"e52628","type":"journal-article","article-title":"Derivation of highly purified cardiomyocytes from human induced pluripotent stem cells using small molecule-modulated differentiation and subsequent glucose starvation","author":"Sharma","year":"2015","unstructured":"Sharma, A. et al. Derivation of highly purified cardiomyocytes from human induced pluripotent stem cells using small molecule-modulated differentiation and subsequent glucose starvation. Journal of Visualized Experiments. (97), e52628 (2015).","journal-title":"Journal of Visualized Experiments"},{"issue":"7337","key":"ref10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nature09747","type":"journal-article","article-title":"Modelling the long QT syndrome with induced pluripotent stem cells","volume":"471","author":"Itzhaki","year":"2011","unstructured":"Itzhaki, I. et al. Modelling the long QT syndrome with induced pluripotent stem cells. Nature. 471 (7337), 225-229 (2011).","journal-title":"Nature"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.stem.2012.10.010","type":"journal-article","article-title":"Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells","volume":"12","author":"Lan","year":"2013","unstructured":"Lan, F. et al. Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. Cell Stem Cell. 12 (1), 101-113 (2013).","journal-title":"Cell Stem Cell"},{"issue":"45","key":"ref12","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1093\/eurheartj\/ehz326","type":"journal-article","article-title":"Modelling diastolic dysfunction in induced pluripotent stem cell-derived cardiomyocytes from hypertrophic cardiomyopathy patients","volume":"40","author":"Wu","year":"2019","unstructured":"Wu, H. et al. Modelling diastolic dysfunction in induced pluripotent stem cell-derived cardiomyocytes from hypertrophic cardiomyopathy patients. European Heart Journal. 40 (45), 3685-3695 (2019).","journal-title":"European Heart Journal"},{"issue":"7769","key":"ref13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41586-019-1406-x","type":"journal-article","article-title":"Activation of PDGF pathway links LMNA mutation to dilated cardiomyopathy","volume":"572","author":"Lee","year":"2019","unstructured":"Lee, J. et al. Activation of PDGF pathway links LMNA mutation to dilated cardiomyopathy. Nature. 572 (7769), 335-340 (2019).","journal-title":"Nature"},{"issue":"130","key":"ref14","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003552","type":"journal-article","article-title":"Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy","volume":"4","author":"Sun","year":"2012","unstructured":"Sun, N. et al. Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Science Translational Medicine. 4 (130), 130ra147 (2012).","journal-title":"Science Translational Medicine"},{"issue":"8","key":"ref15","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abk0052","type":"journal-article","article-title":"Activation of PDGFRA signaling contributes to filamin C-related arrhythmogenic cardiomyopathy","volume":"8","author":"Chen","year":"2022","unstructured":"Chen, S. N. et al. Activation of PDGFRA signaling contributes to filamin C-related arrhythmogenic cardiomyopathy. Science Advances. 8 (8), eabk0052 (2022).","journal-title":"Science Advances"},{"issue":"377","key":"ref16","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf2584","type":"journal-article","article-title":"High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells","volume":"9","author":"Sharma","year":"2017","unstructured":"Sharma, A. et al. High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells. Science Translational Medicine. 9 (377) (2017).","journal-title":"Science Translational Medicine"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nm.4087","type":"journal-article","article-title":"Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity","volume":"22","author":"Burridge","year":"2016","unstructured":"Burridge, P. W. et al. Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity. Nature Medicine. 22 (5), 547-556 (2016).","journal-title":"Nature Medicine"},{"issue":"21","key":"ref18","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1161\/CIRCULATIONAHA.118.037357","type":"journal-article","article-title":"Human-induced pluripotent stem cell model of trastuzumab-induced cardiac dysfunction in patients with breast cancer","volume":"139","author":"Kitani","year":"2019","unstructured":"Kitani, T. et al. Human-induced pluripotent stem cell model of trastuzumab-induced cardiac dysfunction in patients with breast cancer. Circulation. 139 (21), 2451-2465 (2019).","journal-title":"Circulation"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.stem.2016.07.006","type":"journal-article","article-title":"Transcriptome profiling of patient-specific human iPSC-cardiomyocytes predicts individual drug safety and efficacy responses in vitro","volume":"19","author":"Matsa","year":"2016","unstructured":"Matsa, E. et al. Transcriptome profiling of patient-specific human iPSC-cardiomyocytes predicts individual drug safety and efficacy responses in vitro. Cell Stem Cell. 19 (3), 311-325 (2016).","journal-title":"Cell Stem Cell"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.19406","type":"journal-article","article-title":"Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells","volume":"6","author":"Stillitano","year":"2017","unstructured":"Stillitano, F. et al. Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells. Elife. 6 (2017).","journal-title":"Elife"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"100859","DOI":"10.1016\/j.xpro.2021.100859","type":"journal-article","article-title":"Protocol to measure contraction, calcium, and action potential in human-induced pluripotent stem cell-derived cardiomyocytes","volume":"2","author":"Zhang","year":"2021","unstructured":"Zhang, J. Z. et al. Protocol to measure contraction, calcium, and action potential in human-induced pluripotent stem cell-derived cardiomyocytes. STAR Protocols. 2 (4), 100859 (2021).","journal-title":"STAR Protocols"},{"issue":"13","key":"ref22","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/j.celrep.2018.08.079","type":"journal-article","article-title":"International multisite study of human-induced pluripotent stem cell-derived cardiomyocytes for drug proarrhythmic potential assessment","volume":"24","author":"Blinova","year":"2018","unstructured":"Blinova, K. et al. International multisite study of human-induced pluripotent stem cell-derived cardiomyocytes for drug proarrhythmic potential assessment. Cell Reports. 24 (13), 3582-3592 (2018).","journal-title":"Cell Reports"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cmpb.2013.09.004","type":"journal-article","article-title":"Ca analysis: an Excel based program for the analysis of intracellular calcium transients including multiple, simultaneous regression analysis","volume":"113","author":"Greensmith","year":"2014","unstructured":"Greensmith, D. J. Ca analysis: an Excel based program for the analysis of intracellular calcium transients including multiple, simultaneous regression analysis. Computer Methods and Programs in Biomedicine. 113 (1), 241-250 (2014).","journal-title":"Computer Methods and Programs in Biomedicine"},{"issue":"23","key":"ref24","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1161\/CIRCULATIONAHA.117.032273","type":"journal-article","article-title":"Determining the pathogenicity of a genomic variant of uncertain significance using CRISPR\/Cas9 and human-induced pluripotent stem cells","volume":"138","author":"Ma","year":"2018","unstructured":"Ma, N. et al. Determining the pathogenicity of a genomic variant of uncertain significance using CRISPR\/Cas9 and human-induced pluripotent stem cells. Circulation. 138 (23), 2666-2681 (2018).","journal-title":"Circulation"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1161\/CIRCRESAHA.118.314202","type":"journal-article","article-title":"Identifying the transcriptome signatures of calcium channel blockers in human induced pluripotent stem cell-derived cardiomyocytes","volume":"125","author":"Lam","year":"2019","unstructured":"Lam, C. K. et al. Identifying the transcriptome signatures of calcium channel blockers in human induced pluripotent stem cell-derived cardiomyocytes. Circulation Research. 125 (2), 212-222 (2019).","journal-title":"Circulation Research"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/CIRCULATIONAHA.118.034624","type":"journal-article","article-title":"A premature termination codon mutation in MYBPC3 causes hypertrophic cardiomyopathy via chronic activation of nonsense-mediated decay","volume":"139","author":"Seeger","year":"2019","unstructured":"Seeger, T. et al. A premature termination codon mutation in MYBPC3 causes hypertrophic cardiomyopathy via chronic activation of nonsense-mediated decay. Circulation. 139 (6), 799-811 (2019).","journal-title":"Circulation"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.stemcr.2020.11.010","type":"journal-article","article-title":"Effects of cryopreservation on human induced pluripotent stem cell-derived cardiomyocytes for assessing drug safety response profiles","volume":"16","author":"Zhang","year":"2021","unstructured":"Zhang, J. Z. et al. Effects of cryopreservation on human induced pluripotent stem cell-derived cardiomyocytes for assessing drug safety response profiles. Stem Cell Reports. 16 (1), 168-181 (2021).","journal-title":"Stem Cell Reports"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11886-022-01670-z","type":"journal-article","article-title":"Deconvoluting the cells of the human heart with iPSC technology: cell types, protocols, and uses","volume":"24","author":"Yu","year":"2022","unstructured":"Yu, B., Zhao, S. R., Yan, C. D., Zhang, M., Wu, J. C. Deconvoluting the cells of the human heart with iPSC technology: cell types, protocols, and uses. Current Cardiology Reports. 24 (5), 487-496 (2022).","journal-title":"Current Cardiology Reports"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/cvr\/cvab115","type":"journal-article","article-title":"Human-induced pluripotent stem cells in cardiovascular research: current approaches in cardiac differentiation, maturation strategies, and scalable production","volume":"118","author":"Thomas","year":"2022","unstructured":"Thomas, D., Cunningham, N. J., Shenoy, S., Wu, J. C. Human-induced pluripotent stem cells in cardiovascular research: current approaches in cardiac differentiation, maturation strategies, and scalable production. Cardiovascular Research. 118 (1), 20-36 (2022).","journal-title":"Cardiovascular Research"},{"issue":"5","key":"ref30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/scrt507","type":"journal-article","article-title":"Physical developmental cues for the maturation of human pluripotent stem cell-derived cardiomyocytes","volume":"5","author":"Zhu","year":"2014","unstructured":"Zhu, R. et al. Physical developmental cues for the maturation of human pluripotent stem cell-derived cardiomyocytes. Stem Cell Research & Therapy. 5 (5), 117 (2014).","journal-title":"Stem Cell Research & Therapy"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"107925","DOI":"10.1016\/j.celrep.2020.107925","type":"journal-article","article-title":"Metabolic maturation media improve physiological function of human iPSC-derived cardiomyocytes","volume":"32","author":"Feyen","year":"2020","unstructured":"Feyen, D. A. M. et al. Metabolic maturation media improve physiological function of human iPSC-derived cardiomyocytes. Cell Reports. 32 (3), 107925 (2020).","journal-title":"Cell Reports"},{"issue":"10","key":"ref32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1161\/RES.0000000000000291","type":"journal-article","article-title":"Use of human induced pluripotent stem cell-derived cardiomyocytes in preclinical cancer drug cardiotoxicity testing: a scientific statement from the American Heart Association","volume":"125","author":"Gintant","year":"2019","unstructured":"Gintant, G. et al. Use of human induced pluripotent stem cell-derived cardiomyocytes in preclinical cancer drug cardiotoxicity testing: a scientific statement from the American Heart Association. Circulation Research. 125 (10), e75-e92 (2019).","journal-title":"Circulation Research"},{"issue":"11","key":"ref33","doi-asserted-by":"crossref","DOI":"10.3390\/cells8111331","type":"journal-article","article-title":"hiPSCs Derived cardiac cells for drug and toxicity screening and disease modeling: what micro- electrode-array analyses can tell us","volume":"8","author":"Kussauer","year":"2019","unstructured":"Kussauer, S., David, R., Lemcke, H. hiPSCs Derived cardiac cells for drug and toxicity screening and disease modeling: what micro- electrode-array analyses can tell us. Cells. 8 (11) (2019).","journal-title":"Cells"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.hrthm.2019.09.020","type":"journal-article","article-title":"High-throughput phenotyping of heteromeric human ether-a-go-go-related gene potassium channel variants can discriminate pathogenic from rare benign variants","volume":"17","author":"Ng","year":"2020","unstructured":"Ng, C. A. et al. High-throughput phenotyping of heteromeric human ether-a-go-go-related gene potassium channel variants can discriminate pathogenic from rare benign variants. Heart Rhythm. 17 (3), 492-500 (2020).","journal-title":"Heart Rhythm"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17460441.2020.1791079","type":"journal-article","article-title":"Automated patch clamp in drug discovery: major breakthroughs and innovation in the last decade","volume":"16","author":"Obergrussberger","year":"2021","unstructured":"Obergrussberger, A., Friis, S., Bruggemann, A., Fertig, N. Automated patch clamp in drug discovery: major breakthroughs and innovation in the last decade. Expert Opinion on Drug Discovery. 16 (1), 1-5 (2021).","journal-title":"Expert Opinion on Drug Discovery"},{"issue":"12","key":"ref36","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.hrthm.2020.05.041","type":"journal-article","article-title":"High-throughput discovery of trafficking-deficient variants in the cardiac potassium channel KV11.1","volume":"17","author":"Kozek","year":"2020","unstructured":"Kozek, K. A. et al. High-throughput discovery of trafficking-deficient variants in the cardiac potassium channel KV11.1. Heart Rhythm. 17 (12), 2180-2189 (2020).","journal-title":"Heart Rhythm"},{"issue":"556","key":"ref37","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay6848","type":"journal-article","article-title":"Predicting functional effects of missense variants in voltage-gated sodium and calcium channels","volume":"12","author":"Heyne","year":"2020","unstructured":"Heyne, H. O. et al. Predicting functional effects of missense variants in voltage-gated sodium and calcium channels. Science Translational Medicine. 12 (556) (2020).","journal-title":"Science Translational Medicine"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"101662","DOI":"10.1016\/j.scr.2019.101662","type":"journal-article","article-title":"Establishment of an automated patch-clamp platform for electrophysiological and pharmacological evaluation of hiPSC-CMs","volume":"41","author":"Li","year":"2019","unstructured":"Li, W. et al. Establishment of an automated patch-clamp platform for electrophysiological and pharmacological evaluation of hiPSC-CMs. Stem Cell Research. 41, 101662 (2019).","journal-title":"Stem Cell Research"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"102565","DOI":"10.1016\/j.scr.2021.102565","type":"journal-article","article-title":"Blebbistatin protects iPSC-CMs from hypercontraction and facilitates automated patch-clamp based electrophysiological study","volume":"56","author":"Li","year":"2021","unstructured":"Li, W., Luo, X., Ulbricht, Y., Guan, K. Blebbistatin protects iPSC-CMs from hypercontraction and facilitates automated patch-clamp based electrophysiological study. Stem Cell Research. 56, 102565 (2021).","journal-title":"Stem Cell Research"},{"key":"ref40","type":"book","volume-title":"Ion Channels: Methods and Protocols","author":"Milligan","year":"2013","unstructured":"Milligan, C. J., M\u00f6ller, C. in Ion Channels: Methods and Protocols. (ed Nikita Gamper). 171-187 Humana Press, (2013)."}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jove.com\/t\/64265\/technical-applications-microelectrode-array-patch-clamp-recordings-on","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:31:51Z","timestamp":1792611111000},"score":1,"resource":{"primary":{"URL":"https:\/\/app.jove.com\/t\/64265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,4]]},"references-count":40,"journal-issue":{"issue":"186","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.3791\/64265","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,4]]}}}